Chapter 138
Xeroderma Pigmentosum and Related Diseases
Steffen Schubert,
Steffen Emmert,
Steffen Schubert
Department of Dermatology, Venereology and Allergology, University Medical Centre Göttingen, Göttingen, Germany
Search for more papers by this authorSteffen Emmert
Clinic for Dermatology and Venereology, University Medical Centre Rostock, Rostock, Germany
Search for more papers by this authorSteffen Schubert,
Steffen Emmert,
Steffen Schubert
Department of Dermatology, Venereology and Allergology, University Medical Centre Göttingen, Göttingen, Germany
Search for more papers by this authorSteffen Emmert
Clinic for Dermatology and Venereology, University Medical Centre Rostock, Rostock, Germany
Search for more papers by this authorBook Editor(s):Peter Hoeger,
Veronica Kinsler,
Albert Yan,
John Harper,
Arnold Oranje,
Christine Bodemer,
Margarita Larralde,
David Luk, Vibhu Mendiratta,
Diana Purvis,
Peter Hoeger
Search for more papers by this authorVeronica Kinsler
Search for more papers by this authorAlbert Yan
Search for more papers by this authorJohn Harper
Search for more papers by this authorArnold Oranje
Search for more papers by this authorChristine Bodemer
Search for more papers by this authorMargarita Larralde
Search for more papers by this authorVibhu Mendiratta
Search for more papers by this authorDiana Purvis
Search for more papers by this authorFirst published: 20 November 2019
Summary
Nucleotide excision repair (NER) is the most versatile DNA repair system in humans. NER can repair a variety of bulky DNA damage including ultraviolet light-induced DNA damage. The consequences of defective NER factors are demonstrated by the three most common but still rare autosomal recessive NER defective syndromes: xeroderma pigmentosum (XP), Cockayne syndrome (CS), and trichothiodystrophy (TTD). XP patients show severe sun sensitivity, freckling in sun exposed skin and develop skin cancers already during childhood. CS patients exhibit sun sensitivity, severe neurological abnormalities and cachectic dwarfism. Clinical features of TTD patients include sun sensitivity, ichthyosis and short brittle sulphur-deficient hair. In contrast to XP patients, CS and TTD patients are not prone to ultraviolet light-induced skin cancers (melanoma, squamous and basal cell carcinomas). Because the genotype–phenotype correlations are complex, these syndromes can serve as disease models for skin cancer development, neurodegeneration and epidermal cell differentiation, potentially leading to new prevention and therapeutic strategies.
References
- Bauer NC, Corbett AH, Doetsch PW. The current state of eukaryotic DNA base damage and repair. Nucleic Acids Res 2015; 43: 10083–101.
- Pan MR, Li K, Lin SY et al. Connecting the dots: from DNA damage and repair to aging. Int J Mol Sci 2016; 17:pii: E685.
- Lindahl T, Wood RD. Quality control by DNA repair. Science 1999; 286: 1897–905.
- Wood RD, Mitchell M, Sgouros J et al. Human DNA repair genes. Science 2001; 291: 1284–9.
- Lee AJ, Warshaw DM, Wallace SS. Insights into the glycosylase search for damage from single-molecule fluorescence microscopy. DNA Repair (Amst) 2014; 20: 23–31.
- Shell SM, Hawkins EK, Tsai MS et al. Xeroderma pigmentosum complementation group C protein (XPC) serves as a general sensor of damaged DNA. DNA Repair (Amst) 2013; 12: 947–53.
- Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73: 39–85.
- Goodman MF, Woodgate R. Translesion DNA polymerases. Cold Spring Harb Perspect Biol 2013; 5: a010363.
- Liu Z, Wang L, Zhong D. Dynamics and mechanisms of DNA repair by photolyase. Phys Chem Chem Phys 2015; 17: 11933–49.
- Thompson CL, Sancar A. Photolyase/cryptochrome blue-light photoreceptors use photon energy to repair DNA and reset the circadian clock. Oncogene 2002; 21: 9043–56.
- Lehmann AR. Replication of damaged DNA by translesion synthesis in human cells. FEBS Lett 2005; 579: 873–6.
- Yuasa M, Masutani C, Eki T et al. Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene. Oncogene 2000; 19: 4721–8.
- Inui H, Oh KS, Nadem C et al. Xeroderma pigmentosum-variant patients from America, Europe, and Asia. J Invest Dermatol 2008; 128: 2055–68.
- Schärer OD. Nucleotide excision repair in eukaryotes. Cold Spring Harb Perspect Biol 2013; 5: a012609.
- Carter RJ, Parsons JL. Base excision repair, a pathway regulated by posttranslational modifications. Mol Cell Biol 2016; 36: 1426–37.
- Groothuizen FS, Sixma TK. The conserved molecular machinery in DNA mismatch repair enzyme structures. DNA Repair (Amst) 2016; 38: 14–23.
- Marti TM, Kunz C, Fleck O. DNA mismatch repair and mutation avoidance pathways. J Cell Physiol 2002; 191: 28–41.
- Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001; 411: 366–74.
- Kraemer KH, Rünger TM. Genome stability, DNA repair and cancer. In: K Wolff, LA Goldsmith, SI Katz et al. (eds) Fitzpatrick's Dermatology in General Medicine. McGraw-Hill: New York, 2008: 977–86.
References
- Schärer OD. Nucleotide excision repair in eukaryotes. Cold Spring Harb Perspect Biol 2013; 5: a012609.
- Leibeling D, Laspe P, Emmert S. Nucleotide excision repair and cancer. J Mol Histol 2006; 37: 225–38.
- Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol 2004; 195: 298–308.
- Wood RD. Mammalian nucleotide excision repair proteins and interstrand crosslink repair. Environ Mol Mutagen 2010; 51: 520–6.
- Kraemer KH, Rünger TM. Genome stability, DNA repair and cancer. In: K Wolff, LA Goldsmith, SI Katz et al. (eds) Fitzpatrick's Dermatology in General Medicine. McGraw-Hill: New York, 2008: 977–86.
- Thoms KM, Kuschal C, Emmert S. Lessons learned from DNA repair defective syndromes. Exp Dermatol 2007; 16: 532–44.
- Kisker C, Kuper J, Van Houten B. Prokaryotic nucleotide excision repair. Cold Spring Harb Perspect Biol 2013; 5: a012591.
- Hanawalt PC. Subpathways of nucleotide excision repair and their regulation. Oncogene 2002; 21: 8949–56.
- Shell SM, Hawkins EK, Tsai MS et al. Xeroderma pigmentosum complementation group C protein (XPC) serves as a general sensor of damaged DNA. DNA Repair (Amst) 2013; 12: 947–53.
- Sugasawa K, Akagi J, Nishi R et al. Two-step recognition of DNA damage for mammalian nucleotide excision repair: directional binding of the XPC complex and DNA strand scanning. Mol Cell 2009; 36: 642–53.
- Sugasawa K. UV-DDB: a molecular machine linking DNA repair with ubiquitination. DNA Repair (Amst) 2009; 8: 969–72.
- Puumalainen MR, Ruthemann P, Min JH et al. Xeroderma pigmentosum group C sensor: unprecedented recognition strategy and tight spatiotemporal regulation. Cell Mol Life Sci 2016; 73: 547–66.
- Brueckner F, Cramer P. DNA photodamage recognition by RNA polymerase II. FEBS Lett 2007; 581: 2757–60.
- Angers S, Li T, Yi X et al. Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature 2006; 443: 590–3.
- Fischer ES, Scrima A, Bohm K et al. The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, targeting, and activation. Cell 2011; 147: 1024–39.
- Aamann MD, Muftuoglu M, Bohr VA et al. Multiple interaction partners for Cockayne syndrome proteins: implications for genome and transcriptome maintenance. Mech Ageing Dev 2013; 134: 212–24.
- Velez-Cruz R, Egly JM. Cockayne syndrome group B (CSB) protein: at the crossroads of transcriptional networks. Mech Ageing Dev 2013; 134: 234–42.
- Jaarsma D, van der Pluijm I, van der Horst GT et al. Cockayne syndrome pathogenesis: lessons from mouse models. Mech Ageing Dev 2013; 134: 180–95.
- Oksenych V, Bernardes de Jesus B, Zhovmer A et al. Molecular insights into the recruitment of TFIIH to sites of DNA damage. EMBO J 2009; 28: 2971–80.
- Mathieu N, Kaczmarek N, Naegeli H. Strand- and site-specific DNA lesion demarcation by the xeroderma pigmentosum group D helicase. Proc Natl Acad Sci U S A 2010; 107: 17545–50.
- Mathieu N, Kaczmarek N, Ruthemann P et al. DNA quality control by a lesion sensor pocket of the xeroderma pigmentosum group D helicase subunit of TFIIH. Curr Biol 2013; 23: 204–12.
- Theil AF, Hoeijmakers JH, Vermeulen W. TTDA: big impact of a small protein. Exp Cell Res 2014; 329: 61–8.
- Theil AF, Nonnekens J, Steurer B et al. Disruption of TTDA results in complete nucleotide excision repair deficiency and embryonic lethality. PLoS Genet 2013; 9: e1003431.
- Fadda E. Role of the XPA protein in the NER pathway: a perspective on the function of structural disorder in macromolecular assembly. Comput Struct Biotechnol J 2016; 14: 78–85.
- Emmert S. Xeroderma pigmentosum, Cockayne syndrome, Trichothiodystrophy – defects in DNA repair and carcinogenesis. In: H Allgayer, H Rehder, S Fulda (eds) Hereditary Tumors. Weinheim: Wiley-VCH2009: 421–39.
- Fagbemi AF, Orelli B, Schärer OD. Regulation of endonuclease activity in human nucleotide excision repair. DNA Repair (Amst) 2011; 10: 722–9.
- Staresincic L, Fagbemi AF, Enzlin JH et al. Coordination of dual incision and repair synthesis in human nucleotide excision repair. EMBO J 2009; 28: 1111–20.
- Ito S, Kuraoka I, Chymkowitch P et al. XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients. Mol Cell 2007; 26: 231–43.
- Schäfer A, Schubert S, Gratchev A et al. Characterization of three XPG-defective patients identifies three missense mutations that impair repair and transcription. J Invest Dermatol 2013; 133: 1841–9.
- Kemp MG, Reardon JT, Lindsey-Boltz LA et al. Mechanism of release and fate of excised oligonucleotides during nucleotide excision repair. J Biol Chem 2012; 287: 22889–99.
- Kemp MG, Sancar A. DNA excision repair: where do all the dimers go? Cell Cycle 2012; 11: 2997–3002.
- Eller MS, Asarch A, Gilchrest BA. Photoprotection in human skin–-a multifaceted SOS response. Photochem Photobiol 2008; 84: 339–49.
- Kemp MG, Gaddameedhi S, Choi JH et al. DNA repair synthesis and ligation affect the processing of excised oligonucleotides generated by human nucleotide excision repair. J Biol Chem 2014; 289: 26574–83.
- Lehmann AR. DNA polymerases and repair synthesis in NER in human cells. DNA Repair (Amst) 2011; 10: 730–3.
- Zhang Y, Tian Y, Chen Q et al. TTDN1 is a Plk1-interacting protein involved in maintenance of cell cycle integrity. Cell Mol Life Sci 2007; 64: 632–40.
- Rünger TM, DiGiovanna JJ, Kraemer KH. Hereditary diseases of genome instability and DNA repair. In: K Wolff, LA Goldsmith, SI Katz et al. (eds) Fitzpatrick's Dermatology in General Medicine. McGraw-Hill: New York, 2008: 1311–25.
- Corbett MA, Dudding-Byth T, Crock PA et al. A novel X-linked trichothiodystrophy associated with a nonsense mutation in RNF113A. J Med Genet 2015; 52: 269–74.
References
- Kraemer KH, Patronas NJ, Schiffmann R et al. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience 2007; 145: 1388–96.
- Moriwaki S. Human DNA repair disorders in dermatology: a historical perspective, current concepts and new insight. J Dermatol Sci 2016; 81: 77–84.
- Rapin I. Disorders of nucleotide excision repair. Handb Clin Neurol 2013; 113: 1637–50.
- Bootsma D, Kraemer KH, Cleaver JE et al. Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. In: B Vogelstein, KW Kinzler (eds) The Genetic Basis of Human Cancer. McGraw-Hill: New York, 2002: 211–37.
- de Boer J, Hoeijmakers JH. Nucleotide excision repair and human syndromes. Carcinogenesis 2000; 21: 453–60.
- Moriz Kaposi (1837–1902 – Disciple of Von Hebra). JAMA 1964; 187: 227–8.
- Emmert S, Leibeling D, Rünger TM. Syndromes with genetic instability: model diseases for (skin) cancerogenesis. J Dtsch Dermatol Ges 2006; 4: 721–31.
- Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum. Nature 1968; 218: 652–6.
- Epstein JH, Fukuyama K, Fye K. Effects of ultraviolet radiation on the mitotic cycle and DNA, RNA and protein synthesis in mammalian epidermis in vivo. Photochem Photobiol 1970; 12: 57–65.
- Epstein JH, Fukuyama K, Reed WB et al. Defect in DNA synthesis in skin of patients with xeroderma pigmentosum demonstrated in vivo. Science 1970; 168: 1477–8.
- De Weerd-Kastelein EA, Keijzer W, Bootsma D. Genetic heterogeneity of xeroderma pigmentosum demonstrated by somatic cell hybridization. Nat New Biol 1972; 238: 80–3.
- Schubert S, Lehmann J, Kalfon L et al. Clinical utility gene card for: Xeroderma pigmentosum. Eur J Hum Genet 2014; 22.
- Leibeling D, Laspe P, Emmert S. Nucleotide excision repair and cancer. J Mol Histol 2006; 37: 225–38.
- Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987; 123: 241–50.
- Kleijer WJ, Laugel V, Berneburg M et al. Incidence of DNA repair deficiency disorders in western Europe: xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair (Amst) 2008; 7: 744–50.
- Khan SG, Oh KS, Shahlavi T et al. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis 2006; 27: 84–94.
- Swift M, Chase C. Cancer in families with xeroderma pigmentosum. J Natl Cancer Inst 1979; 62: 1415–21.
- Masaki T, Wang Y, DiGiovanna JJ et al. High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients. Pigment Cell Melanoma Res 2014; 27: 454–64.
- Kraemer KH, Slor H. Xeroderma pigmentosum. Clin Dermatol 1985; 3: 33–69.
- Seebode C, Lehmann J, Emmert S. Photocarcinogenesis and skin cancer prevention strategies. Anticancer Res 2016; 36: 1371–8.
- Kraemer KH, Sander M, Bohr VA. New areas of focus at workshop on human diseases involving DNA repair deficiency and premature aging. Mech Ageing Dev 2007; 128: 229–35.
- Emmert S. Xeroderma pigmentosum, Cockayne syndrome, trichothiodystrophy – defects in DNA repair and carcinogenesis. In: H Allgayer, H Rehder, S Fulda (eds) Hereditary Tumors. Weinheim: Wiley-VCH2009: 421–39.
- DiGiovanna JJ, Kraemer KH. Shining a light on xeroderma pigmentosum. J Invest Dermatol 2012; 132: 785–96.
- Bradford PT, Goldstein AM, Tamura D et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet 2011; 48: 168–76.
- Muramoto O, Mukoyama M, Nonaka I et al. [De Sanctis-Cacchione syndrome: a report of a case and a review of the literature (author's transl)]. Rinsho Shinkeigaku 1981; 21: 986–92.
- Fu L, Xu X, Ren R et al. Modeling xeroderma pigmentosum associated neurological pathologies with patients-derived iPSCs. Protein Cell 2016; 7: 210–21.
- Viana LM, Seyyedi M, Brewer CC et al. Histopathology of the inner ear in patients with xeroderma pigmentosum and neurologic degeneration. Otol Neurotol 2013; 34: 1230–6.
- Melis JP, van Steeg H, Luijten M. Oxidative DNA damage and nucleotide excision repair. Antioxid Redox Signal 2013; 18: 2409–19.
- Lagerqvist A, Hakansson D, Lundin C et al. DNA repair and replication influence the number of mutations per adduct of polycyclic aromatic hydrocarbons in mammalian cells. DNA Repair (Amst) 2011; 10: 877–86.
- Khan SG, Levy HL, Legerski R et al. Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia. J Invest Dermatol 1998; 111: 791–6.
- Lehmann J, Schubert S, Emmert S. Xeroderma pigmentosum: diagnostic procedures, interdisciplinary patient care, and novel therapeutic approaches. J Dtsch Dermatol Ges 2014; 12: 867–72.
- Inui H, Oh KS, Nadem C et al. Xeroderma pigmentosum-variant patients from America, Europe, and Asia. J Invest Dermatol 2008; 128: 2055–68.
- Tamura D, DiGiovanna JJ, Khan SG et al. Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients. Photodermatol Photoimmunol Photomed 2014; 30: 146–52.
-
Sharquie KE, Ibrahim GA. Is the skin graft immune against new malignancy? J Saudi Soci Dermatol Dermatol Surg 2011; 15: 73–5.
10.1016/j.jssdds.2011.04.004 Google Scholar
- Hess MT, Gunz D, Luneva N et al. Base pair conformation-dependent excision of benzo[a]pyrene diol epoxide-guanine adducts by human nucleotide excision repair enzymes. Mol Cell Biol 1997; 17: 7069–76.
- Cafardi JA, Elmets CA. T4 endonuclease V: review and application to dermatology. Expert Opin Biol Ther 2008; 8: 829–38.
- Feltes BC, Bonatto D. Overview of xeroderma pigmentosum proteins architecture, mutations and post-translational modifications. Mutat Res Rev Mutat Res 2015; 763: 306–20.
- van Steeg H, Kraemer KH. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol Med Today 1999; 5: 86–94.
- Ito S, Kuraoka I, Chymkowitch P et al. XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients. Mol Cell 2007; 26: 231–43.
- Singh A, Compe E, Le May N et al. TFIIH subunit alterations causing xeroderma pigmentosum and trichothiodystrophy specifically disturb several steps during transcription. Am J Hum Genet 2015; 96: 194–207.
- Ziani S, Nagy Z, Alekseev S et al. Sequential and ordered assembly of a large DNA repair complex on undamaged chromatin. J Cell Biol 2014; 206: 589–98.
- Le May N, Fradin D, Iltis I et al. XPG and XPF endonucleases trigger chromatin looping and DNA demethylation for accurate expression of activated genes. Mol Cell 2012; 47: 622–32.
- Sugitani N, Sivley RM, Perry KE et al. XPA: a key scaffold for human nucleotide excision repair. DNA Repair (Amst) 2016; 44: 123–5.
- Oh KS, Khan SG, Jaspers NG et al. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome. Hum Mutat 2006; 27: 1092–103.
- Compe E, Egly JM. TFIIH: when transcription met DNA repair. Nat Rev Mol Cell Biol 2012; 13: 343–54.
- Ben Rekaya M, Messaoud O, Talmoudi F et al. High frequency of the V548A fs X572 XPC mutation in Tunisia: implication for molecular diagnosis. J Hum Genet 2009; 54: 426–9.
- Chavanne F, Broughton BC, Pietra D et al. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res 2000; 60: 1974–82.
- Schäfer A, Hofmann L, Gratchev A et al. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations. Exp Dermatol 2013; 22: 24–9.
- Soufir N, Ged C, Bourillon A et al. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa. J Invest Dermatol 2010; 130: 1537–42.
- Robbins JH. Xeroderma pigmentosum. Defective DNA repair causes skin cancer and neurodegeneration. JAMA 1988; 260: 384–8.
- Fong YW, Inouye C, Yamaguchi T et al. A DNA repair complex functions as an Oct4/Sox2 coactivator in embryonic stem cells. Cell 2011; 147: 120–31.
-
Le May N, Egly JM, Coin F. True lies: the double life of the nucleotide excision repair factors in transcription and DNA repair. J Nucleic Acids 2010; 2010: 1–10.
10.4061/2010/616342 Google Scholar
- Lehmann AR. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev 2001; 15: 15–23.
- Liu H, Rudolf J, Johnson KA et al. Structure of the DNA repair helicase XPD. Cell 2008; 133: 801–12.
- Kuper J, Braun C, Elias A et al. In TFIIH, XPD helicase is exclusively devoted to DNA repair. PLoS Biol 2014; 12: e1001954.
- Mathieu N, Kaczmarek N, Ruthemann P et al. DNA quality control by a lesion sensor pocket of the xeroderma pigmentosum group D helicase subunit of TFIIH. Curr Biol 2013; 23: 204–12.
- Spies M. DNA repair: trust but verify. Curr Biol 2013; 23: R115–7.
- Matsumoto S, Fischer ES, Yasuda T et al. Functional regulation of the DNA damage-recognition factor DDB2 by ubiquitination and interaction with xeroderma pigmentosum group C protein. Nucleic Acids Res 2015; 43: 1700–13.
- Bennett D, Itoh T. The XPE gene of xeroderma pigmentosum, its product and biological roles. Adv Exp Med Biol 2008; 637: 57–64.
- Kashiyama K, Nakazawa Y, Pilz DT et al. Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia. Am J Hum Genet 2013; 92: 807–19.
- Bogliolo M, Schuster B, Stoepker C et al. Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genet 2013; 92: 800–6.
- Niedernhofer LJ, Garinis GA, Raams A et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 2006; 444: 1038–43.
- Jaspers NG, Raams A, Silengo MC et al. First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure. Am J Hum Genet 2007; 80: 457–66.
- Kraemer KH, Rünger TM. Genome stability, DNA repair and cancer. In: K Wolff, LA Goldsmith, SI Katz et al. (eds) Fitzpatrick's Dermatology in General Medicine. McGraw-Hill: New York, 2008: 977–86.
- Lehmann J, Schubert S, Schäfer A et al. An unusual mutation in the XPG gene leads to an internal in-frame deletion and a XP/CS complex phenotype. Br J Dermatol 2014; 171: 903–5.
- Schäfer A, Schubert S, Gratchev A et al. Characterization of three XPG-defective patients identifies three missense mutations that impair repair and transcription. J Invest Dermatol 2013; 133: 1841–9.
- Soltys DT, Rocha CR, Lerner LK et al. Novel XPG (ERCC5) mutations affect DNA repair and cell survival after ultraviolet but not oxidative stress. Hum Mutat 2013; 34: 481–9.
- Klungland A, Hoss M, Gunz D et al. Base excision repair of oxidative DNA damage activated by XPG protein. Mol Cell 1999; 3: 33–42.
- Gratchev A, Strein P, Utikal J et al. Molecular genetics of Xeroderma pigmentosum variant. Exp Dermatol 2003; 12: 529–36.
- Cockayne EA. Dwarfism with retinal atrophy and deafness. Arch Dis Child 1936; 11: 1–8.
- Cockayne EA. Dwarfism with retinal atrophy and deafness. Arch Dis Child 1946; 21: 52–4.
- Neill CA, Dingwall MM. A syndrome resembling progeria: a review of two cases. Arch Dis Child 1950; 25: 213–23.
- Lehmann AR, Thompson AF, Harcourt SA et al. Cockayne's syndrome: correlation of clinical features with cellular sensitivity of RNA synthesis to UV irradiation. J Med Genet 1993; 30: 679–82.
- Wilson BT, Stark Z, Sutton RE et al. The Cockayne Syndrome Natural History (CoSyNH) study: clinical findings in 102 individuals and recommendations for care. Genet Med 2016; 18: 483–93.
- Wilson DM, 3rd, Bohr VA. Special issue on the segmental progeria Cockayne syndrome. Mech Ageing Dev 2013; 134: 159–60.
- Nance MA, Berry SA. Cockayne syndrome: review of 140 cases. Am J Med Genet 1992; 42: 68–84.
- Lindenbaum Y, Dickson D, Rosenbaum P et al. Xeroderma pigmentosum/cockayne syndrome complex: first neuropathological study and review of eight other cases. Eur J Paediatr Neurol 2001; 5: 225–42.
- Brooks PJ. Blinded by the UV light: how the focus on transcription-coupled NER has distracted from understanding the mechanisms of Cockayne syndrome neurologic disease. DNA Repair (Amst) 2013; 12: 656–71.
- Velez-Cruz R, Egly JM. Cockayne syndrome group B (CSB) protein: at the crossroads of transcriptional networks. Mech Ageing Dev 2013; 134: 234–42.
- Scheibye-Knudsen M, Croteau DL, Bohr VA. Mitochondrial deficiency in Cockayne syndrome. Mech Ageing Dev 2013; 134: 275–83.
- D'Errico M, Pascucci B, Iorio E et al. The role of CSA and CSB protein in the oxidative stress response. Mech Ageing Dev 2013; 134: 261–9.
- Wagner AM. Xeroderma pigmentosum, Cockayne's syndrome and trichothiodystrophy. In: J Harper, A Oranje, N Prose (eds) Textbook of Pediatric Dermatology. Wiley-Blackwell: Weinheim, 2006: 1557–82.
- Rastogi RP, Richa, Kumar A et al. Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair. J Nucleic Acids 2010; 2010: 592980.
- Yokoyama H, Mizutani R, Satow Y et al. Structure of the DNA (6-4) photoproduct dTT(6-4)TT in complex with the 64M-2 antibody Fab fragment implies increased antibody-binding affinity by the flanking nucleotides. Acta Crystallogr D Biol Crystallogr 2012; 68: 232–8.
- Thoms KM, Kuschal C, Emmert S. Lessons learned from DNA repair defective syndromes. Exp Dermatol 2007; 16: 532–44.
- Lehmann AR. Three complementation groups in Cockayne syndrome. Mutat Res 1982; 106: 347–56.
- Miyauchi H, Horio T, Akaeda T et al. Cockayne syndrome in two adult siblings. J Am Acad Dermatol 1994; 30: 329–35.
- Mallery DL, Tanganelli B, Colella S et al. Molecular analysis of mutations in the CSB (ERCC6) gene in patients with Cockayne syndrome. Am J Hum Genet 1998; 62: 77–85.
- Saijo M, Hirai T, Ogawa A et al. Functional TFIIH is required for UV-induced translocation of CSA to the nuclear matrix. Mol Cell Biol 2007; 27: 2538–47.
- Fischer ES, Scrima A, Bohm K et al. The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, targeting, and activation. Cell 2011; 147: 1024–39.
- Groisman R, Kuraoka I, Chevallier O et al. CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome. Genes Dev 2006; 20: 1429–34.
- Aamann MD, Muftuoglu M, Bohr VA et al. Multiple interaction partners for Cockayne syndrome proteins: implications for genome and transcriptome maintenance. Mech Ageing Dev 2013; 134: 212–24.
- Beerens N, Hoeijmakers JH, Kanaar R et al. The CSB protein actively wraps DNA. J Biol Chem 2005; 280: 4722–9.
- Emmert S, Slor H, Busch DB et al. Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients. J Invest Dermatol 2002; 118: 972–82.
- Rapin I, Lindenbaum Y, Dickson DW et al. Cockayne syndrome and xeroderma pigmentosum. Neurology 2000; 55: 1442–9.
- Arab HH, Wani G, Ray A et al. Dissociation of CAK from core TFIIH reveals a functional link between XP-G/CS and the TFIIH disassembly state. PLoS One 2010; 5: e11007.
- Price VH, Odom RB, Ward WH et al. Trichothiodystrophy: sulfur-deficient brittle hair as a marker for a neuroectodermal symptom complex. Arch Dermatol 1980; 116: 1375–84.
- Lambert WC, Gagna CE, Lambert MW. Trichothiodystrophy: photosensitive, TTD-P, TTD, Tay syndrome. Adv Exp Med Biol 2010; 685: 106–10.
- Stefanini M, Lagomarsini P, Arlett CF et al. Xeroderma pigmentosum (complementation group D) mutation is present in patients affected by trichothiodystrophy with photosensitivity. Hum Genet 1986; 74: 107–12.
- Itin PH, Sarasin A, Pittelkow MR. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J Am Acad Dermatol 2001; 44: 891–920; quiz 1–4.
- Stefanini M, Botta E, Lanzafame M et al. Trichothiodystrophy: from basic mechanisms to clinical implications. DNA Repair (Amst) 2010; 9: 2–10.
- Faghri S, Tamura D, Kraemer KH et al. Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. J Med Genet 2008; 45: 609–21.
- Brauns B, Schubert S, Lehmann J et al. Photosensitive form of trichothiodystrophy associated with a novel mutation in the XPD gene. Photodermatol Photoimmunol Photomed 2016; 32: 110–2.
- Van Neste DJ, Gillespie JM, Marshall RC et al. Morphological and biochemical characteristics of trichothiodystrophy-variant hair are maintained after grafting of scalp specimens on to nude mice. Br J Dermatol 1993; 128: 384–7.
- Priolo M, Silengo M, Lerone M et al. Ectodermal dysplasias: not only 'skin' deep. Clin Genet 2000; 58: 415–30.
- Cui CY, Schlessinger D. EDA signaling and skin appendage development. Cell Cycle 2006; 5: 2477–83.
- Weeda G, Eveno E, Donker I et al. A mutation in the XPB/ERCC3 DNA repair transcription gene, associated with trichothiodystrophy. Am J Hum Genet 1997; 60: 320–9.
- Stefanini M, Vermeulen W, Weeda G et al. A new nucleotide-excision-repair gene associated with the disorder trichothiodystrophy. Am J Hum Genet 1993; 53: 817–21.
- Giglia-Mari G, Coin F, Ranish JA et al. A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A. Nat Genet 2004; 36: 714–9.
- Lehmann AR, Bootsma D, Clarkson SG et al. Nomenclature of human DNA repair genes. Mutat Res 1994; 315: 41–2.
- Marteijn JA, Lans H, Vermeulen W et al. Understanding nucleotide excision repair and its roles in cancer and ageing. Nat Rev Mol Cell Biol 2014; 15: 465–81.
- Theil AF, Hoeijmakers JH, Vermeulen W. TTDA: big impact of a small protein. Exp Cell Res 2014; 329: 61–8.
- Botta E, Offman J, Nardo T et al. Mutations in the C7orf11 (TTDN1) gene in six nonphotosensitive trichothiodystrophy patients: no obvious genotype-phenotype relationships. Hum Mutat 2007; 28: 92–6.
- Heller ER, Khan SG, Kuschal C et al. Mutations in the TTDN1 gene are associated with a distinct trichothiodystrophy phenotype. J Invest Dermatol 2015; 135: 734–41.
- Corbett MA, Dudding-Byth T, Crock PA et al. A novel X-linked trichothiodystrophy associated with a nonsense mutation in RNF113A. J Med Genet 2015; 52: 269–74.
- Broughton BC, Berneburg M, Fawcett H et al. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene. Hum Mol Genet 2001; 10: 2539–47.
- Graham JM, Jr., Hennekam R, Dobyns WB et al. MICRO syndrome: an entity distinct from COFS syndrome. Am J Med Genet A 2004; 128A: 235–45.
- Graham JM, Jr., Anyane-Yeboa K, Raams A et al. Cerebro-oculo-facio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy. Am J Hum Genet 2001; 69: 291–300.
- Meira LB, Graham JM, Jr., Greenberg CR et al. Manitoba aboriginal kindred with original cerebro-oculo- facio-skeletal syndrome has a mutation in the Cockayne syndrome group B (CSB) gene. Am J Hum Genet 2000; 66: 1221–8.
- Hosseini M, Ezzedine K, Taieb A et al. Oxidative and energy metabolism as potential clues for clinical heterogeneity in nucleotide excision repair disorders. J Invest Dermatol 2015; 135: 341–51.
- Itoh T, Ono T, Yamaizumi M. A new UV-sensitive syndrome not belonging to any complementation groups of xeroderma pigmentosum or Cockayne syndrome: siblings showing biochemical characteristics of Cockayne syndrome without typical clinical manifestations. Mutat Res 1994; 314: 233–48.
- Nardo T, Oneda R, Spivak G et al. A UV-sensitive syndrome patient with a specific CSA mutation reveals separable roles for CSA in response to UV and oxidative DNA damage. Proc Natl Acad Sci U S A 2009; 106: 6209–14.
- Horibata K, Iwamoto Y, Kuraoka I et al. Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome. Proc Natl Acad Sci U S A 2004; 101: 15410–5.
References
- Swift M, Chase C. Cancer in families with xeroderma pigmentosum. J Natl Cancer Inst 1979; 62: 1415–21.
- Thoms KM, Kuschal C, Emmert S. Lessons learned from DNA repair defective syndromes. Exp Dermatol 2007; 16: 532–44.
- Schäfer A, Hofmann L, Gratchev A et al. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations. Exp Dermatol 2013; 22: 24–9.
- Khan SG, Oh KS, Shahlavi T et al. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis 2006; 27: 84–94.
- Athma P, Rappaport R, Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 1996; 92: 130–4.
- Gruber SB, Ellis NA, Scott KK et al. BLM heterozygosity and the risk of colorectal cancer. Science 2002; 297: 2013.
- Goss KH, Risinger MA, Kordich JJ et al. Enhanced tumor formation in mice heterozygous for Blm mutation. Science 2002; 297: 2051–3.
References
- Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120: 513–22.
- Courtois-Cox S, Jones SL, Cichowski K. Many roads lead to oncogene-induced senescence. Oncogene 2008; 27: 2801–9.
- Cortopassi GA, Wang E. There is substantial agreement among interspecies estimates of DNA repair activity. Mech Ageing Dev 1996; 91: 211–8.
- Hart RW, Setlow RB. Correlation between deoxyribonucleic acid excision -repair and life-span in a number of mammalian species. Proc Natl Acad Sci U S A 1974: 2169–73.
- Tyner SD, Venkatachalam S, Choi J et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002; 415: 45–53.
- Baker DJ, Wijshake T, Tchkonia T et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479: 232–6.
- Wong KK, Maser RS, Bachoo RM et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 2003; 421: 643–8.
- Ruzankina Y, Pinzon-Guzman C, Asare A et al. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 2007; 1: 113–26.
- Moldovan GL, D'Andrea AD. How the fanconi anemia pathway guards the genome. Annu Rev Genet 2009; 43: 223–49.
- Thoms KM, Kuschal C, Emmert S. Lessons learned from DNA repair defective syndromes. Exp Dermatol 2007; 16: 532–44.
- Lancini C, van den Berk PC, Vissers JH et al. Tight regulation of ubiquitin-mediated DNA damage response by USP3 preserves the functional integrity of hematopoietic stem cells. J Exp Med 2014; 211: 1759–77.
- Cai Q, Fu L, Wang Z et al. alpha-N-methylation of damaged DNA-binding protein 2 (DDB2) and its function in nucleotide excision repair. J Biol Chem 2014; 289: 16046–56.
- Bonsignore LA, Tooley JG, Van Hoose PM et al. NRMT1 knockout mice exhibit phenotypes associated with impaired DNA repair and premature aging. Mech Ageing Dev 2015; 146–148: 42–52.
- Roy N, Stoyanova T, Dominguez-Brauer C et al. DDB2, an essential mediator of premature senescence. Mol Cell Biol 2010; 30: 2681–92.
- Soskic V, Groebe K, Schrattenholz A. Nonenzymatic posttranslational protein modifications in ageing. Exp Gerontol 2008; 43: 247–57.
- Gella A, Durany N. Oxidative stress in Alzheimer disease. Cell Adh Migr 2009; 3: 88–93.
- Vermeij WP, Hoeijmakers JH, Pothof J. Genome Integrity in Aging: Human Syndromes, Mouse Models, and Therapeutic Options. Annu Rev Pharmacol Toxicol 2016; 56: 427–45.
- Goodell MA, Rando TA. Stem cells and healthy aging. Science 2015; 350: 1199–204.
- Lee HW, Blasco MA, Gottlieb GJ et al. Essential role of mouse telomerase in highly proliferative organs. Nature 1998; 392: 569–74.
- Starr ME, Evers BM, Saito H. Age-associated increase in cytokine production during systemic inflammation: adipose tissue as a major source of IL-6. J Gerontol A Biol Sci Med Sci 2009; 64: 723–30.
- Maggio M, Guralnik JM, Longo DL et al. Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci 2006; 61: 575–84.
- Pan MR, Li K, Lin SY et al. Connecting the dots: from DNA damage and repair to aging. Int J Mol Sci 2016; 17:p.ii: E685.
References
- Thoms KM, Kuschal C, Emmert S. Lessons learned from DNA repair defective syndromes. Exp Dermatol 2007; 16: 532–44.
- Zheng Y, Luo X, Zhu J et al. Mitochondrial DNA 4977 bp deletion is a common phenomenon in hair and increases with age. Bosn J Basic Med Sci 2012; 12: 187–92.
- Fang EF, Scheibye-Knudsen M, Chua KF et al. Nuclear DNA damage signalling to mitochondria in ageing. Nat Rev Mol Cell Biol 2016; 17: 308–21.
- Lee MH, Wang L, Chang ZF. The contribution of mitochondrial thymidylate synthesis in preventing the nuclear genome stress. Nucleic Acids Res 2014; 42: 4972–84.
- Stevnsner T, Nyaga S, de Souza-Pinto NC et al. Mitochondrial repair of 8-oxoguanine is deficient in Cockayne syndrome group B. Oncogene 2002; 21: 8675–82.
- Kujoth GC, Bradshaw PC, Haroon S et al. The role of mitochondrial DNA mutations in mammalian aging. PLoS Genet 2007; 3: e24.
- Fang EF, Scheibye-Knudsen M, Brace LE et al. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction. Cell 2014; 157: 882–96.
- Canto C, Menzies KJ, Auwerx J. NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metab 2015; 22: 31–53.
- Gibson BA, Kraus WL. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Biol 2012; 13: 411–24.
- Rodgers JT, Lerin C, Haas W et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005; 434: 113–8.
- Mouchiroud L, Houtkooper RH, Moullan N et al. The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 2013; 154: 430–41.
- Fan W, Luo J. SIRT1 regulates UV-induced DNA repair through deacetylating XPA. Mol Cell 2010; 39: 247–58.
- Ross JM, Oberg J, Brene S et al. High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A/B ratio. Proc Natl Acad Sci U S A 2010; 107: 20087–92.
- Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell Metab 2014; 19: 181–92.
- Scheibye-Knudsen M, Mitchell SJ, Fang EF et al. A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in cockayne syndrome. Cell Metab 2014; 20: 840–55.
- Scheibye-Knudsen M, Ramamoorthy M, Sykora P et al. Cockayne syndrome group B protein prevents the accumulation of damaged mitochondria by promoting mitochondrial autophagy. J Exp Med 2012; 209: 855–69.
References
- Yarosh D, Klein J, O'Connor A et al. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet 2001; 357: 926–9.
- Yarosh DB. DNA repair, immunosuppression, and skin cancer. Cutis 2004; 74(5 Suppl): 10–3.
- Stege H, Roza L, Vink AA et al. Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc Natl Acad Sci U S A 2000; 97: 1790–5.
- Kuschal C, DiGiovanna JJ, Khan SG et al. Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons. Proc Natl Acad Sci U S A 2013; 110: 19483–8.
- Lehmann J, Schubert S, Emmert S. Xeroderma pigmentosum: diagnostic procedures, interdisciplinary patient care, and novel therapeutic approaches. J Dtsch Dermatol Ges 2014; 12: 867–72.
